What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which play a major role in your weight and weight loss, says Dr. Russo. These ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British ...

Ozempic, Wegovy and Mounjaro are often the most popular weight loss drugs. While these medications help people lose weight, they have undesirable side effects. Now, scientists at the University of ...

Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...

Fierce Healthcare hosted its second annual in-person Payer Summit conference in Austin, Texas, on Nov. 13-14. | Fierce Healthcare's Payer Summit took place in Austin, Texas on Nov. 13-14. Industry ...

The effects appeared to rely on more than just improved in blood sugar control or weight reduction, the authors said, and ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...

Analysts look at the likelihood of lawmakers making moves to rein in drug middlemen this session. Also, covid-era prescription flexibility is kept in place, pharmaceutical companies take on GLP-1 ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

And actually, as the GLP-1s have actually continued to expand throughout the community, that’s where many of the initial ...